The metabolism of 5, 5-diphenylhydantoin was studied in the newborn human in two instances; one involved direct administration of the drug, and the other was by placental transfer of the drug from the mother. 5-(3,4-Dihydroxy-1, 5-cyclohexadien-1-yl)-5-phenylhydantoin was found to be a major metabolite. The GC and GC-MS methods employed here are well suited to the problem of studying drug metabolism in the newborn.
No takes yet. Share an insight, caveat, or question.
Horning et al. (1971) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: